Amnean Therapeutics Profile
Key Indicators
- Authorised Capital ₹ 7.00 Cr
- Paid Up Capital ₹ 6.86 Cr
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
- Revenue Growth 877.70%
- Profit Growth -3.89%
- Ebitda -29.54%
- Net Worth -1123.51%
- Total Assets 5.95%
About Amnean Therapeutics
Amnean Therapeutics Private Limited (ATPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 May 2012 and has a history of 12 years and nine months. Its registered office is in Mahabub Nagar, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 Cr and a paid-up capital of Rs 6.86 Cr.
The company currently has active open charges totaling ₹5.00 Cr.
Venkateswara Srikonda, Sharada Pochampally, Mahaboob Shaik, and One other member serve as directors at the Company.
Company Details
- Location
Mahabub Nagar, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24232TG2012PTC081046
- Company No.
081046
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 May 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Amnean Therapeutics Private Limited
Explore comprehensive data for Amnean Therapeutics Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Amnean Therapeutics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Bangalore  | Director | 21-May-2012 | Current |
Venkateswara Srikonda  | Director | 21-May-2012 | Current |
| Sharada Pochampally | Director | 20-Aug-2012 | Current |
| Mahaboob Shaik | Director | 20-Aug-2012 | Current |
Financial Performance of Amnean Therapeutics.
Amnean Therapeutics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 877.7% increase. The company also saw a slight decrease in profitability, with a 3.89% decrease in profit. The company's net worth observed a substantial decline by a decrease of 1123.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amnean Therapeutics?
In 2022, Amnean Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Prime Care Super Speciality Hospital Llp
Mahaboob Shaik is a mutual person
Charges (Loans)
Open Charges
₹5.00 Cr
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 5.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Aug 2016 | Others | ₹5.00 Cr | Open |
How Many Employees Work at Amnean Therapeutics?
Unlock and access historical data on people associated with Amnean Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amnean Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amnean Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Amnean Therapeutics
Recent activity within the organization
- Annual General Meeting
Amnean Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Amnean Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100044209 was registered on 05 Aug 2016.
- Director Appointment
Sharada Pochampally was appointed as a Director was appointed as a Director on 20 Aug 2012 & has been associated with this company since 12 years 6 months .
- Director Appointment
Mahaboob Pasha Shaik was appointed as a Director was appointed as a Director on 20 Aug 2012 & has been associated with this company since 12 years 6 months .
- Director Appointment
Venkateswara Sastry Srikonda was appointed as a Director was appointed as a Director on 21 May 2012 & has been associated with this company since 12 years 9 months .
Frequently asked questions
What is the Incorporation or founding date of Amnean Therapeutics Private Limited?
Amnean Therapeutics Private Limited was incorporated on 21 May 2012.
What is authorized share capital and paid-up capital of Amnean Therapeutics Private Limited?
The authorized share capital of Amnean Therapeutics Private Limited is ₹ 7.00 Cr and paid-up capital is ₹ 6.86 Cr.
Who are the current board members & directors of Amnean Therapeutics Private Limited?
Currently 4 directors are associated with Amnean Therapeutics Private Limited.
- Venkateswara Sastry Srikonda
- Sharada Pochampally
- Mahaboob Pasha Shaik
- Ramesh Bangalore
What is the registered address of Amnean Therapeutics Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Amnean Therapeutics Private Limited is Plot No. L18/1 2 7 8 Polepally Sez Rajapur Mandal, India, Jadcherla, Telangana, 509301.
What is the corporate identification number (CIN) and company number of Amnean Therapeutics Private Limited?
The corporate identification number (CIN) of Amnean Therapeutics Private Limited is U24232TG2012PTC081046 and the company number is 081046 as per Ministry of Corporate Affairs (MCA).
What is the official website of Amnean Therapeutics Private Limited?
The Official website of Amnean Therapeutics Private Limited is https://www.amnean.com
What has been the recent revenue trend for Amnean Therapeutics Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Amnean Therapeutics Private Limited has risen by 877.70%.
What change has been observed in the net worth of Amnean Therapeutics Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Amnean Therapeutics Private Limited has experienced an downturn of -1123.51%.
What are the total open charges for Amnean Therapeutics Private Limited?
As per the financial statements for fiscal Year 2022, The total open charges for Amnean Therapeutics Private Limited amount to ₹ 5.00 Cr.
When was the last Balance Sheet of Amnean Therapeutics Private Limited filed with the ROC?
The most recent Balance Sheet for Amnean Therapeutics Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records